| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.04 |